Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02435797

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Xuzhou Central Hospital (from the registry)
Registry
  • NCT NCT02435797
Other papers using this trial's data
  • Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Heart, lung & circulation, 2019-06 DOI, PubMed 29891250

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02435797. Randomized; single masking; primary purpose prevention. Start 2015-04 (registry gives no type); primary completion 2015-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction
Condition
Coronary Heart Disease
Intervention (Drug)
Nicorandil
Intervention (Drug)
normal saline
Lead sponsor
Xuzhou Central Hospital (class: other)

Record details

Record id
cardio:ct-nct02435797
Content hash
15dc62252d33a58fe502c667b47224659b751e14b8b54061e7fc5f9d9ed12451